A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Obesity Surgery

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11695-017-2913-1PMID 28871519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A short or a long Roux limb in gastric bypass surgery: does it matter?

  2017cited by this paper
• Does length of common limb influence remission of diabetes? Short-term results

  2016cited by this paper
• The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.

  2016cited by this paper
• Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study

  2016cited by this paper
• Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide

  2015cited by this paper
• Prevalence of Obesity Among Adults and Youth: United States, 2011-2014.

  2015cited by this paper
• Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.

  2015cited by this paper
• The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review

  2015cited by this paper
• Calorie Restriction is a Major Determinant of the Short‐Term Metabolic Effects of Gastric Bypass Surgery in Obese Type 2 Diabetic Patients

  2014cited by this paper
• Prevalence of childhood and adult obesity in the United States, 2011-2012.

  2014cited by this paper
• Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

  2014cited by this paper
• Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?

  2014cited by this paper
• Surgical Treatment of Type 2 Diabetes in Subjects with Mild Obesity: Mechanisms Underlying Metabolic Improvements

  2014cited by this paper
• Effects of Meal Size on the Release of GLP-1 and PYY After Roux-en-Y Gastric Bypass Surgery in Obese Subjects With or Without Type 2 Diabetes

  2014cited by this paper
• Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes

  2013cited by this paper
• A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass

  2013cited by this paper
• Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

  2013cited by this paper
• Lower Glycemic Fluctuations Early After Bariatric Surgery Partially Explained by Caloric Restriction

  2013cited by this paper
• Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese Subjects

  2013cited by this paper
• Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats.

  2013cited by this paper
• Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

  2013cited by this paper
• Differential Effects of Laparoscopic Sleeve Gastrectomy and Laparoscopic Gastric Bypass on Appetite, Circulating Acyl-ghrelin, Peptide YY3-36 and Active GLP-1 Levels in Non-diabetic Humans

  2013cited by this paper
• Effects of Gastrogastric Fistula Repair on Weight Loss and Gut Hormone Levels

  2013cited by this paper
• Relationships among tonic and episodic aspects of motivation to eat, gut peptides, and weight before and after bariatric surgery.

  2013cited by this paper
• Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

  2012cited by this paper
• The medical care costs of obesity: an instrumental variables approach.

  2012cited by this paper
• Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery

  2012cited by this paper
• Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction

  2012cited by this paper
• Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial

  2012cited by this paper
• Lower Ghrelin Levels and Exaggerated Postprandial Peptide-YY, Glucagon-Like Peptide-1, and Insulin Responses, After Gastric Fundus Resection, in Patients Undergoing Roux-en-Y Gastric Bypass: A Randomized Clinical Trial

  2012cited by this paper
• Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.

  2011cited by this paper
• The effects of an amino acid supplement on glucose homeostasis, inflammatory markers, and incretins after laparoscopic gastric bypass.

  2011cited by this paper
• The Importance of the Length of the Limbs for Gastric Bypass Patients—An Evidence-based Review

  2011cited by this paper
• Short Versus Long Roux-Limb Length in Roux-en-Y Gastric Bypass Surgery for the Treatment of Morbid and Super Obesity: a Systematic Review of the Literature

  2011cited by this paper
• Early Improvement in Glycemic Control After Bariatric Surgery and Its Relationships with Insulin, GLP-1, and Glucagon Secretion in Type 2 Diabetic Patients

  2011cited by this paper
• Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

  2011cited by this paper
• Effects of Gastric Bypass Surgery on Insulin Resistance and Insulin Secretion in Nondiabetic Obese Patients

  2011cited by this paper
• Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

  2010cited by this paper
• Effect of gastric bypass surgery on the incretins.

  2009cited by this paper
• Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass

  2009cited by this paper
• Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost

  2009cited by this paper
• Five-year outcome with gastric bypass: Roux limb length makes a difference.

  2008cited by this paper
• The effects of Roux-en-Y limb length on gastric emptying and enterogastric reflux in rats.

  2008cited by this paper
• Effects of bariatric surgery on mortality in Swedish obese subjects.

  2007cited by this paper
• The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes

  2006cited by this paper
• Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety

  2006cited by this paper
• GLP-1 and Changes in Glucose Tolerance following Gastric Bypass Surgery in Morbidly Obese Subjects

  2006cited by this paper
• The Mechanisms of Surgical Treatment of Type 2 Diabetes

  2005cited by this paper
• The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism

  2004cited by this paper
• Motility in the Roux‐Y limb after distal gastrectomy: relation to the length of the limb and the afferent duodenojejunal segment – an experimental study

  1999cited by this paper
• Gastric bypass in obesity.

  1967cited by this paper

• Obesity and Weight Management in HIV: Epidemiology, Complications, and Emerging Treatments

  2026cites this paper
• Changes of Gut Microbiota, Hormone and Glycolipid Metabolism by Dietary Fiber (Oat Bran) Supplementation in Patients with Laparoscopic Sleeve Gastrectomy and Roux-en-Y gastric Bypass: a Randomized Controlled Study

  2026cites this paper
• Effects of GLP-1 and GIP on cholinergic-induced contractility in isolated jejunal muscle from obese patients with and without type 2 diabetes mellitus

  2026cites this paper
• Implications of Metabolic Bariatric Surgery on Reproductive Health

  2025cites this paper
• GLP-1 and GIP may play a role in long-term weight trajectories after gastric bypass

  2025cites this paper
• β-Cell Function and Sensitivity to Incretins Before and After Roux-en-Y Gastric Bypass in Individuals With Type 2 Diabetes.

  2025cites this paper
• Prospective Observational Study on Perioperative Dysgeusia and Trace Metal Elements in Patients Undergoing Pancreatoduodenectomy

  2025cites this paper
• Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota.

  2025cites this paper
• Weight loss therapy and addiction: increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists.

  2025cites this paper
• Evaluation of l-cell activity in the small intestine according to the extension of the biliopancreatic loop in patients undergoing Roux-en-Y gastric by-pass

  2025cites this paper
• In-depth analysis of metabolic hormones and inflammatory markers following Roux-en-Y gastric bypass in humans and rodents: Similarities and differences.

  2025cites this paper
• Using obesity management medications within the first year after laparoscopic sleeve gastrectomy may enhance weight-loss outcomes

  2025cites this paper
• Laparoscopic Roux-En-Y gastric bypass versus mini-gastric bypass for the treatment of morbid obesity and effect on glucagon-like peptide-1 level: a randomized comparative study

  2024cites this paper
• Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels

  2024cites this paper
• Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates

  2024cites this paper
• Normalization of WISP1 circulating level and tissue expression following metabolic and bariatric surgery using rat model

  2024cites this paper
• Obesity-related cancer and bariatric surgery: A comprehensive systematic review and meta-analysis protocol

  2024cites this paper
• Metabolic and bariatric surgery: an update from 2010.

  2024cites this paper
• Impact of Recurrent Weight Gain Thresholds on Comorbid Conditions Progression Following Laparoscopic Sleeve Gastrectomy

  2024cites this paper
• Gut motility and hormone changes after bariatric procedures

  2024cites this paper
• What could be the reasons for not losing weight even after following a weight loss program?

  2024cites this paper
• Weight Regain after Metabolic Surgery: Beyond the Surgical Failure

  2024cites this paper
• Gut peptides before and following Roux‐En‐Y gastric bypass: A systematic review and meta‐analysis

  2024cites this paper
• Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes.

  2024cites this paper
• Regulation of Pancreatic TXNIP-Insulin Expression Levels after Bariatric Surgery Using Diabetic Rodent Model

  2023cites this paper
• Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity.

  2023cites this paper
• RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine

  2023cites this paper
• Metabolic bariatric surgery in face of new anti-obesity medications-10 + 1 challenges

  2023cites this paper
• Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments

  2023cites this paper
• Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.

  2023cites this paper
• Evaluation of hormonal and circulating inflammatory biomarker profiles in the year following bariatric surgery

  2023cites this paper
• Weight loss trend after bariatric surgery in a population of obese patients.

  2023cites this paper
• Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production

  2023cites this paper
• Rare variants of the glucagon-like peptide-1 receptor (GLP1R) gene are overrepresented in a severe obesity cohort and associated with type 2 diabetes in the UK Biobank

  2023cites this paper
• Dual effect of RYGB on the entero-insular axis: how GLP-1 is enhanced by surgical duodenal exclusion.

  2023cites this paper
• Characteristics and outcomes for patients undergoing revisional bariatric surgery due to persistent obesity: a retrospective cohort study of 10,589 patients

  2023cites this paper
• Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Meta-analysis

  2023cites this paper
• Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study

  2022cites this paper
• The Impact of Bariatric Surgery on Bone Health: State of the Art and New Recognized Links.

  2022cites this paper
• New Options (or not) for Treatment of Idiopathic Intracranial Hypertension

  2022cites this paper
• Appetite Changes in Weight Regain and Weight Maintenance After Roux-en-Y Gastric Bypass

  2022cites this paper
• Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis

  2022cites this paper
• Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass

  2022cites this paper
• Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.

  2022cites this paper
• Effect of Weight Regain on Body Composition and Metabolic Biomarkers After Sleeve Gastrectomy: a Cross-Sectional Study from a Hospital Database

  2022cites this paper
• BYPASS-OMA: Hypoglycemic Hyperinsulinemic Nesidioblastosis after Gastric Bypass Surgery—A Case Report and Review of the Literature

  2022cites this paper
• Role of Gastrointestinal Hormones as a Predictive Factor for Long-Term Diabetes Remission: Randomized Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy, and Greater Curvature Plication

  2021cites this paper
• Long-Term Weight Outcomes after Bariatric Surgery: A Single Center Saudi Arabian Cohort Experience

  2021cites this paper
• Glucagon-like peptid-1 in obese and diabetic patients after bariatric interventions

  2021cites this paper
• Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective.

  2021cites this paper
• Intestinal alteration of a-gustducin and sweet taste signaling pathway in metabolic diseases is partly rescued after weight loss and diabetes remission.

  2021cites this paper
• Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature

  2021cites this paper
• Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?

  2021cites this paper
• Improved Beta-Cell Function and Altered Plasma Levels of GLP-1 During OMTT and Fasting Following Bariatric Surgery in Women with NGT

  2021cites this paper
• Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes

  2021cites this paper
• The gut–brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders

  2021cites this paper
• Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps—a Scoping Review

  2021cites this paper
• Vascular repair and regeneration in cardiometabolic diseases.

  2021cites this paper
• Roux-en-Y gastric bypass surgery in Zucker rats induces bacterial and systemic metabolic changes independent of caloric restriction-induced weight loss

  2021cites this paper
• Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery

  2021cites this paper
• Order of Discontinuation of Glucose-lowering Medications following Bariatric Surgery.

  2020cites this paper
• The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study

  2020cites this paper
• A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease

  2020cites this paper
• Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery.

  2020cites this paper
• What predicts the unsuccess of bariatric surgery? An observational retrospective study

  2020cites this paper
• Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study

  2020cites this paper
• Bariatric and Metabolic Therapies Targeting the Small Intestine.

  2020cites this paper
• Impact of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy on gut microbiota: a metagenomic comparative analysis.

  2020cites this paper
• From Entero-Endocrine Cell Biology to Surgical Interventional Therapies for Type 2 Diabetes.

  2020cites this paper
• Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery

  2020cites this paper
• Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis.

  2020cites this paper
• Bipartição de trânsito intestinal isolada: uma nova estratégia para cirurgia em estágios em superobesos. Isolated intestinal transit bipartition: a new strategy for staged surgery in superobesity.

  2019cites this paper
• Metabolic and Endocrine Consequences of Bariatric Surgery

  2019cites this paper
• The role of gut hormones in obesity

  2019cites this paper
• Systematic Review and Meta-analysis of the Change in Ghrelin Levels After Roux-en-Y Gastric Bypass

  2019cites this paper
• Management of Diabetes in Patients Undergoing Bariatric Surgery

  2019cites this paper
• The role of gut hormones in the pathogenesis and management of obesity

  2019cites this paper
• Isolated intestinal transit bipartition: a new strategy for staged surgery in superobesity.

  2019cites this paper
• Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1

  2018influential citation
• Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery

  2018cites this paper
• Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention

  2018cites this paper
• Venous blood provides lower glucagon‐like peptide‐1 concentrations than arterialized blood in the postprandial but not the fasted state: Consequences of sampling methods

  2018cites this paper
• Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes

  2018cites this paper
• Laparoscopic Roux-en-Y gastric bypass profoundly changes gut microbiota compared to laparoscopic sleeve gastrectomy: a metagenomic comparative analysis

  2018cites this paper
• Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery

  2018cites this paper
• Differences in Calcium Metabolism and Thyroid Physiology After Sleeve Gastrectomy and Roux-En-Y Gastric Bypass

  2018cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper